NCT01957150 - Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD). | Biotech Hunter

Enrollment

283

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Fluticasone Furoate/Vilanterol

Dry white powder containing 100 mcg of Fluticasone Furoate blended with lactose per blister was administered by NDPI. Dry white powder containing 25 mcg of Vilanterol micronised drug (as the 'M' salt triphenylacetate) blended with lactose and magnesium stearate per blister was administered by NDPI.

DRUG

Vilanterol

Dry white powder containing 25 mcg of Vilanterol micronised drug (as the 'M' salt triphenylacetate) blended with lactose and magnesium stearate per blister was administered by NDPI.

Trial Locations (45)

10787

GSK Investigational Site, Berlin

12157

GSK Investigational Site, Berlin

16508

GSK Investigational Site, Erie

22143

GSK Investigational Site, Hamburg

24411

GSK Investigational Site, Ponferrada (León)

28223

GSK Investigational Site, Pozuelo de Alarcón/Madrid

28401

GSK Investigational Site, Wilmington

29303

GSK Investigational Site, Spartanburg

29707

GSK Investigational Site, Old Point Station

30046

GSK Investigational Site, Lawrenceville

33316

GSK Investigational Site, Fort Lauderdale

35501

GSK Investigational Site, Jasper

37007

GSK Investigational Site, Salamanca

37404

GSK Investigational Site, Chattanooga

37919

GSK Investigational Site, Knoxville

51069

GSK Investigational Site, Cologne

55402

GSK Investigational Site, Minneapolis

55441

GSK Investigational Site, Plymouth

56068

GSK Investigational Site, Koblenz

60596

GSK Investigational Site, Frankfurt am Main

63263

GSK Investigational Site, Neu-Isenburg

78229

GSK Investigational Site, San Antonio

85006

GSK Investigational Site, Phoenix

97504

GSK Investigational Site, Medford

99216

GSK Investigational Site, Spokane Valley

68123-4303

GSK Investigational Site, Bellevue

29406-7108

GSK Investigational Site, Charleston

T8H 0N2

GSK Investigational Site, Sherwood Park

R2H 2A6

GSK Investigational Site, Winnipeg

M5T 3A9

GSK Investigational Site, Toronto

G1V 4G5

GSK Investigational Site, Québec

J6E 2B4

GSK Investigational Site, Saint-Charles-Borromée

1815 JD

GSK Investigational Site, Alkmaar

6191 JW

GSK Investigational Site, Beek

6716 RP

GSK Investigational Site, Ede

5623 EJ

GSK Investigational Site, Eindhoven

7555 DL

GSK Investigational Site, Hengelo

1624 NP

GSK Investigational Site, Hoorn

7581 BV

GSK Investigational Site, Losser

6367 TM

GSK Investigational Site, Voerendaal

08017

GSK Investigational Site, Barcelona

03004

GSK Investigational Site, Alicante

08025

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, L'Hospitalet de Llobregat

06800

GSK Investigational Site, Mérida (Badajoz)